`
Transparency Market Research Prenatal and New-born Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Published Date 2014-03-21
87 Page Report
Buy Now
Request Sample
Press Release
Global Market for Prenatal and Newborn Genetic Testing to be Worth USD 8.37 billion by 2019: Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Prenatal and New-born Genetic Testing Market
REPORT DESCRIPTION
Prenatal and New-born Genetic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 In its latest report published recently, U.S.-based market research firm Transparency Market Research estimates the global market for Prenatal and Newborn Genetic Testing to be worth USD 8.37 billion by 2019. This report also projects the CAGR of this industry be 26.9% over the forecast period. The report, titled ‘Prenatal and Newborn Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019’ offers comprehensive insights into the global market based on the growth potential of key testing procedures, the geographical markets for the same, and factors propelling this market ahead. According to the study, the total market for newborn and prenatal genetic testing was valued at USD 1.12 billion in as of 2012, and the growth estimates show that it is poised for exponential growth in the coming years. Browse the full Prenatal and New-born Genetic Testing Market Report @ : http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html Prenatal and newborn genetic testing employs the use of diagnostic or screening techniques to detect chromosomal abnormalities in a new born baby or a fetus. These abnormalities include: Edward syndrome, Down syndrome, and Patau syndrome. With the effective use of such screening and testing procedures, it is possible to detect certain types of genetic abnormalities early on in the gestation period (as early as eight to ten weeks), besides determining the sex of the fetus. There is a growing awareness among pregnant women to undergo such screening and testing procedures so as to ensure a healthy future for their offspring. The Northwestern Medical Faculty Foundation states that nearly 85% pregnant women are advised to undergo screening or testing for birth defects such as trisomy 18, open neural tube defects, and Down syndrome.
Transparency Market Research
2
Prenatal and New-born Genetic Testing Market
Additionally, there are a number of other tests that allow medical practitioners to determine defects such as trisomy 13 and other chromosome abnormalities. The report classifies newborn and prenatal genetic tests into two major categories: screening tests and diagnostic tests. While the former helps detect the change of specific genetic abnormalities developing in a new born or fetus, the latter is used essentially for confirming the presence of such conditions in a new born or fetus. Browse the full Prenatal and New-born Genetic Testing Market Press Release @ : http://www.transparencymarketresearch.com/pressrelease/prenatal-new-borngenetic-testing-market.htm There are multiple factors propelling the growth of the prenatal and newborn genetic testing market. These include: late pregnancies, technological advancements, increase in the maternal age, and a rising awareness pertaining to fetal genetic disorders. Based on in-depth analyses, the report states that there are several emerging opportunities in this market as it is still regarded as being at a nascent stage. A large potential for developing business opportunities exists in developing countries in Asia, Latin America, and Africa. The report also comprises an analysis of the market based on diagnostic techniques employed. It notes that the segment of polymerase chain reaction (PCR) constituted the largest share, followed by aCGH and FISH. The report attributes this to the growth in genetic diseases and forensics, besides other advantages of PCR such as high precision and reliability, better process efficiency, and amplification. Get Free Sample Report : http://www.transparencymarketresearch.com/sample/sample.php? flag=s&rep_id=1744 The largest segment within the screening market is that of non-invasive prenatal testing (NIPT), according to the report; this market is projected to witness the highest CAGR of 37.6% between 2013 and 2019. Furthermore, the report also offers a detailed overview of the global prenatal and newborn genetic testing market by geography. Another section that is of special importance within the report is that of ‘Company Profiles’ as endeavors to keep market players abreast of important information pertaining to their competitors.
Transparency Market Research
3
Prenatal and New-born Genetic Testing Market
TABLE OF CONTENT
Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019) 2.2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million)
Chapter 3 Prenatal and Newborn Genetic Testing Market Overview 3.1 Introduction and Market Definition 3.2 Future Market Outlook 3.3 Regulatory and Reimbursement Scenario for Prenatal and Newborn Screening 3.4 Market Dynamics 3.4.1 Drivers 3.4.2 Restraints
Transparency Market Research
4
Prenatal and New-born Genetic Testing Market
3.4.3 Market Opportunities 3.5 Porter’s Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis
Chapter 4 Prenatal and Newborn Genetic Testing Market, by Technology 4.1 Overview 4.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 – 2019 (USD Million) 4.2 Diagnostic Techniques 4.2.1 Global Diagnostic Techniques Market Revenue, by Types, 2012 – 2019 (USD Million) 4.2.2 Polymerase Chain Reaction (PCR) 4.2.3 Fluorescence In-Situ Hybridization (FISH) 4.2.4 Array-Comparative Genomic Hybridization (aCGH) 4.3 Screening Methods 4.3.1 Global Screening Methods Market Revenue, by Types, 2012 – 2019 (USD Million)
Transparency Market Research
5
Prenatal and New-born Genetic Testing Market
4.3.2 Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test) 4.3.3 Maternal Serum Screening (MSS)
Chapter 5 Prenatal and Newborn Genetic Testing Market, by Geography 5.1 Overview 5.1.1 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography2012 – 2019 (USD Million) 5.2 North America 5.2.1 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) 5.2.2 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.2.3 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) 5.3 Europe 5.3.1 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 2019 (USD Million) 5.3.2 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.3.3 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) 5.4 Asia - Pacific
Transparency Market Research
6
Prenatal and New-born Genetic Testing Market
5.4.1 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) 5.4.2 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.4.3 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 2019 (USD Million) 5.5.2 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) 5.5.3 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
Chapter 6 Competitive Landscape 6.1 Market Share Analysis, by Key Players, 2012 (%)
Chapter 7 Recommendations 7.1 Market Strategy for Success 7.1.1 Focus on forming alliances with diagnostic service providers in Asia-Pacific countries 7.1.2 Emphasis on improving technology in order to increase accuracy, reduce the duration of result generation and price 7.2 Barriers and Future Assumptions
Transparency Market Research
7
Prenatal and New-born Genetic Testing Market
7.2.1 Lack of awareness about prenatal and newborn genetic testing in some Asian countries 7.2.2 Regulatory compliance and ethical issues
Chapter 8 Company Profiles 8.1 Agilent Technologies, Inc. 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Ariosa Diagnostics, Inc. 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 Bio-Rad Laboratories, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview
Transparency Market Research
8
Prenatal and New-born Genetic Testing Market
8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Illumina, Inc. 8.4.1 Company Overview 8.4.2 Financial Performance 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Recent Developments 8.5 Laboratory Corporation of America Holdings (LabCorp) 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Natera, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies
Transparency Market Research
9
Prenatal and New-born Genetic Testing Market
8.6.5 Recent Developments 8.7 PerkinElmer, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Sequenom, Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments List of Figures
FIG. 1 Prenatal and Newborn Genetic Testing: Market Segmentation FIG. 2 Global Prenatal and Newborn Genetic Testing Market, by Segments, 2012 (USD Million) FIG. 3 Adoption Curve Analysis for Genetic Testing Market FIG. 4 Porter’s Five Forces Analysis: Global Prenatal and Newborn Genetic Testing Market
Transparency Market Research
10
Prenatal and New-born Genetic Testing Market
FIG. 5 Market Attractiveness Analysis: Global Prenatal and Newborn Genetic Testing Market, 2012 FIG. 6 Global PCR Market Revenue, 2012 – 2019 (USD Million) FIG. 7 FISH Procedural Steps FIG. 8 Global FISH Market Revenue, 2012 – 2019 (USD Million) FIG. 9 Global aCGH Market Revenue, 2012 – 2019 (USD Million) FIG. 10 Global NIPT Market Revenue, 2012 – 2019 (USD Million) FIG. 11 Global MSS Market Revenue, 2012 – 2019 (USD Million) FIG. 12 Global Prenatal and Newborn Genetic Testing: Market Share, by Key Players, 2012 (%) FIG. 13 Annual Sales: Agilent Technologies, Inc., 2010 – 2012 (USD Million) FIG. 14 Annual Sales: Bio-Rad Laboratories, Inc., Clinical Diagnostics Segment, 2010 – 2012 (USD Million) FIG. 15 Annual Sales: Illumina, Inc., 2010 – 2012 (USD million) FIG. 16 Annual Sales: LabCorp, 2010– 2012 (USD Million) FIG. 17 Annual Sales: PerkinElmer, Inc. (Human Health Segment), 2010 – 2012 (USD Million) FIG. 18 Annual Sales: Sequenom Inc., 2010–2012 (USD Million) List of Tables
TABLE 1 Market Snapshot: Global Prenatal and Newborn Genetic Testing Market (2012 & 2019) TABLE 2 Technological Approach for Non-Invasive Prenatal Screening Tests
Transparency Market Research
11
Prenatal and New-born Genetic Testing Market
TABLE 3 Global Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 – 2019 (USD Million) TABLE 4 Global Diagnostic Techniques Market Revenue, by Types, 2012 – 2019 (USD Million) TABLE 5 Global Screening Methods Market Revenue, by Types, 2012 – 2019 (USD Million) TABLE 6 Global Prenatal and Newborn Genetic Testing Market Revenue, by Geography, 2012 – 2019 (USD Million) TABLE 7 North America Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) TABLE 8 North America Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 9 North America Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 10 Europe Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) TABLE 11 Europe Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 12 Europe Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 13 Asia-Pacific Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 - 2019 (USD Million) TABLE 14 Asia-Pacific Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 15 Asia-Pacific Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 16 RoW Prenatal and Newborn Genetic Testing Market Revenue, by Technology, 2012 2019 (USD Million)
Transparency Market Research
12
Prenatal and New-born Genetic Testing Market
TABLE 17 RoW Diagnostic Techniques Market Revenue, by Types, 2012 - 2019 (USD Million) TABLE 18 RoW Screening Methods Market Revenue, by Types, 2012 - 2019 (USD Million)
Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports18.html About Us
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/
Transparency Market Research
13